Nana Kimura
Overview
Explore the profile of Nana Kimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horikawa M, Fukasawa M, Machi J, Urushihara H, Furuhara Y, Sunakawa A, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
52(1):19-24.
PMID: 39957218
Pancreatic cancer is known as a disease with an extremely poor prognosis. Although surgery is the only curative treatment, most pancreatic cancer is already advanced at the time of diagnosis....
2.
Imaoka H, Ikeda M, Kobayashi S, Ohba A, Ueno M, Suzuki Y, et al.
J Gastroenterol
. 2025 Jan;
60(3):368-369.
PMID: 39878838
No abstract available.
3.
Shirai Y, Kimura N, Tanaka H, Fukasawa M, Muranushi R, Watanabe T, et al.
Pancreas
. 2024 Dec;
PMID: 39626192
Background: Liver recurrence after resection is one of the most common types of recurrence and is a risk factor for poor prognosis. The aim of this study was to identify...
4.
Imaoka H, Ikeda M, Kobayashi S, Ohba A, Ueno M, Suzuki Y, et al.
J Gastroenterol
. 2024 Nov;
60(3):356-367.
PMID: 39614927
Background: S-1 monotherapy had previously been widely used as a second-line treatment for pancreatic cancer (PC) after gemcitabine-based chemotherapy mainly in Japan. Based on the results of the NAPOLI-1 trial,...
5.
Ito M, Watanabe T, Oga Y, Matsumoto S, Kimura N, Nagamori M, et al.
Clin J Gastroenterol
. 2024 Oct;
18(1):208-213.
PMID: 39402396
A 72-year-old woman was diagnosed with unresectable pancreatic body-tail cancer (cT4N1M1, cStage IV) with para-aortic lymph node metastasis. She underwent six courses of gemcitabine + nab-paclitaxel as first-line chemotherapy, 12...
6.
Watanabe T, Nagaoka Y, Kimura N, Fukasawa M, Shirai Y, Hirano K, et al.
Clin J Gastroenterol
. 2024 Jun;
17(5):970-975.
PMID: 38836973
Pancreatic acinar cell carcinoma (PACC) is a rare type of pancreatic cancer; further, its pathogenesis and treatment strategies remain unclear. We report the case of a 70-year-old man who presented...
7.
Matsumoto S, Okumura T, Miwa T, Numata Y, Hamashima T, Ito M, et al.
Surg Case Rep
. 2024 May;
10(1):131.
PMID: 38805072
Background: Glomus tumors (GT) generally occur in the skin. However, esophageal GT, an extremely rare condition, has no established standardized treatment guidelines. Herein, we report the case of an esophageal...
8.
Kimura N, Igarashi T, Murotani K, Itoh A, Watanabe T, Hirano K, et al.
Ann Gastroenterol Surg
. 2024 Mar;
8(2):301-311.
PMID: 38455496
Background: There have been few studies of countermeasures against postoperative cholangitis, a serious complication after pancreaticoduodenectomy (PD) that impairs quality of life. Objective: To evaluate our recently developed, novel method...
9.
Igarashi T, Fukasawa M, Watanabe T, Kimura N, Itoh A, Tanaka H, et al.
Ann Gastroenterol Surg
. 2024 Jan;
8(1):124-132.
PMID: 38250680
Introduction: The prognosis of pancreatic ductal adenocarcinoma (PDAC) in patients with positive peritoneal washing cytology (CY1) is poor. We aimed to evaluate the results of staging laparoscopy (SL) and treatment...
10.
Fukasawa M, Watanabe T, Tanaka H, Itoh A, Kimura N, Shibuya K, et al.
J Hepatobiliary Pancreat Sci
. 2023 Sep;
30(11):1261-1272.
PMID: 37750024
Background: The frequency and prognosis of positive peritoneal washing cytology (CY1) in resectable pancreatic ductal adenocarcinoma (R-PDAC) remains unclear. The objective of this study was to identify the clinical implications...